China Cyts Tours Stock Current Valuation

600138 Stock   10.55  0.12  1.15%   
Valuation analysis of China CYTS Tours helps investors to measure China CYTS's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, China CYTS's End Period Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 668.8 M, whereas Cash is forecasted to decline to about 807.4 M. Fundamental drivers impacting China CYTS's valuation include:
Price Book
1.1976
Enterprise Value
12.5 B
Enterprise Value Ebitda
21.9832
Price Sales
0.7589
Forward PE
27.1739
Overvalued
Today
10.55
Please note that China CYTS's price fluctuation is not too volatile at this time. Calculation of the real value of China CYTS Tours is based on 3 months time horizon. Increasing China CYTS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since China CYTS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Stock. However, China CYTS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  10.55 Real  8.83 Hype  10.58
The real value of China Stock, also known as its intrinsic value, is the underlying worth of China CYTS Tours Company, which is reflected in its stock price. It is based on China CYTS's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China CYTS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
8.83
Real Value
10.65
Upside
Estimating the potential upside or downside of China CYTS Tours helps investors to forecast how China stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China CYTS more accurately as focusing exclusively on China CYTS's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.000.000.00
Details
Hype
Prediction
LowEstimatedHigh
8.7610.5812.40
Details

China CYTS Tours Company Current Valuation Analysis

China CYTS's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current China CYTS Current Valuation

    
  12.47 B  
Most of China CYTS's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, China CYTS Tours is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, China CYTS Tours has a Current Valuation of 12.47 B. This is 31.11% lower than that of the Hotels, Restaurants & Leisure sector and 17.61% lower than that of the Consumer Discretionary industry. The current valuation for all China stocks is 24.99% higher than that of the company.

China Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China CYTS's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of China CYTS could also be used in its relative valuation, which is a method of valuing China CYTS by comparing valuation metrics of similar companies.
China CYTS is currently under evaluation in current valuation category among its peers.

China Fundamentals

About China CYTS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze China CYTS Tours's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China CYTS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China CYTS Tours based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

China CYTS financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China CYTS security.